PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 111 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $85,882 | +15.1% | 33,812 | -15.2% | 0.00% | – |
Q4 2022 | $74,594 | -71.9% | 39,890 | -61.3% | 0.00% | -100.0% |
Q3 2022 | $265,000 | +197.8% | 102,968 | +124.3% | 0.00% | – |
Q2 2022 | $89,000 | +8800.0% | 45,910 | +11377.5% | 0.00% | – |
Q1 2022 | $1,000 | -97.8% | 400 | -96.1% | 0.00% | – |
Q4 2021 | $46,000 | -34.3% | 10,137 | -29.2% | 0.00% | – |
Q3 2021 | $70,000 | -81.3% | 14,316 | -74.0% | 0.00% | – |
Q2 2021 | $375,000 | +182.0% | 55,021 | +192.4% | 0.00% | – |
Q1 2021 | $133,000 | -84.9% | 18,820 | -86.6% | 0.00% | -100.0% |
Q4 2020 | $882,000 | +93.4% | 140,902 | +67.1% | 0.00% | +100.0% |
Q3 2020 | $456,000 | +338.5% | 84,316 | +322.3% | 0.00% | – |
Q2 2020 | $104,000 | +62.5% | 19,965 | -1.9% | 0.00% | -100.0% |
Q1 2020 | $64,000 | -34.0% | 20,358 | -15.0% | 0.00% | 0.0% |
Q4 2019 | $97,000 | +115.6% | 23,953 | +132.1% | 0.00% | – |
Q3 2019 | $45,000 | +462.5% | 10,320 | +448.4% | 0.00% | – |
Q2 2019 | $8,000 | -97.2% | 1,882 | -88.2% | 0.00% | -100.0% |
Q4 2017 | $286,000 | -59.9% | 15,987 | -43.8% | 0.00% | -66.7% |
Q3 2017 | $714,000 | +10100.0% | 28,432 | +9538.0% | 0.01% | – |
Q2 2017 | $7,000 | – | 295 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |